Advertisement
Advertisement

CAI

C

Caris Life Sciences, Inc. Common Stock

28.38
USD
Sponsored
+1.96
+7.44%
Jan 06, 15:59 UTC -5
Closed
exchange

After-Market

28.39

+0.02
+0.07%

CAI Earnings Reports

Positive Surprise Ratio

CAI beat 1 of 2 last estimates.

50%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q3 25 (Revenue/ EPS)
--
/
--
Implied change from Q-- -1 (Revenue/ EPS)
--
/
--

Caris Life Sciences, Inc. Common Stock earnings per share and revenue

On Nov 05, 2025, CAI reported earnings of 0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 138.66% surprise. Revenue reached 216.83 million, compared to an expected 171.86 million, with a 26.17% difference. The market reacted with a -15.75% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, Caris Life Sciences, Inc. Common Stock reported EPS of $0.08, beating estimates by 138.66%, and revenue of $216.83M, 26.17% above expectations.
The stock price moved down -15.75%, changed from $29.21 before the earnings release to $24.61 the day after.
The next earning report is scheduled for --.
Based on -- analysts, Caris Life Sciences, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement